Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.47 USD
Change Today -1.67 / -4.50%
Volume 1.1M
SGEN On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

SGEN

Industry Average

Ratio data TTM as of 12/31/2014

Profitability - seattle genetics inc (SGEN)

Return on Assets

Industry Comparison
-10.26%

Return on Equity

Industry Comparison
-34.53%

Return on Capital

Industry Comparison
-21.93%

Margin Analysis - seattle genetics inc (SGEN)

Gross Margin

Industry Comparison
9.40%

Levered Free Cash Flow Margin

Industry Comparison
-6.04%

EBITDA Margin

Industry Comparison
-22.62%

SG&A Margin

Industry Comparison
36.38%

Asset Turnover - seattle genetics inc (SGEN)

Total Assets Turnover

Industry Comparison
0.6x

Accounts Receivables Turnover

Industry Comparison
8.3x

Fixed Assets Turnover

Industry Comparison
6.6x

Inventory Turnover

Industry Comparison
7.4x

Credit Ratios - seattle genetics inc (SGEN)

Current Ratio

Industry Comparison
3.2x

Quick Ratio

Industry Comparison
2.8x

Long-Term Solvency - seattle genetics inc (SGEN)

Total Debt/Equity

Industry Comparison
--
No data available

Total Liabilities/Total Assets

Industry Comparison
54.06%

Growth Over Prior Year - seattle genetics inc (SGEN)

Total Revenue

Industry Comparison
6.50%

Tangible Book Value

Industry Comparison
-8.21%

EBITDA

Industry Comparison
19.59%

Gross Profit

Industry Comparison
-8.60%

Receivables

Industry Comparison
33.01%

Inventory

Industry Comparison
60.50%

Diluted EPS Before Extra

Industry Comparison
19.98%

Capital Expenditures

Industry Comparison
-22.47%

Cash From Ops.

Industry Comparison
5,305.32%

Levered Free Cash Flow

Industry Comparison
88.39%
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $35.47 USD -1.67

SGEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ARIAD Pharmaceuticals Inc $9.05 USD -0.66
Genmab A/S kr560.00 DKK +14.50
Insys Therapeutics Inc $56.42 USD -6.00
MorphoSys AG €66.50 EUR +0.79
Pfizer Ltd/India 2,030 INR -16.10
View Industry Companies
 

Industry Analysis

SGEN

Industry Average

Valuation SGEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.0x
Price/Book 21.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.